![GENERIC DRUGS](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
![GENERIC DRUGS](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
GENERIC DRUGS
FDA Should Make Public Its Plans to Issue and Revise Guidance on Nonbiological Complex Drugs
-
- USD 19.99
-
- USD 19.99
Descripción editorial
Generic versions of brand-name drugs provide substantial cost savings for patients and the U.S. health care system. FDA, an agency within the Department of Health and Human Services (HHS), has approved generic versions of NBCDs. Some industry stakeholders have asserted that, because it is difficult to assess equivalence for these complex drugs, there could be safety and efficacy problems that might not appear until after generic versions are on the market...
Más libros de Hugues Dumont
Les droits de l’homme, bouclier ou épée du droit pénal ?
2019
Traduction et droits européens : enjeux d’une rencontre
2019
Le pluralisme idéologique et l’autonomie culturelle en droit public belge - vol. 1
2019
Le droit malgré tout
2019
Le décret du 24 juillet 1997 définissant les missions prioritaires de l’enseignement
2019
Politique culturelle et droit de la radio-télévision
2019